BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 6
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10020)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series.
Item 
Count 
PDF849
HTML8995
Figures (1-2)176
 Sum=10020
Feb 14, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(6): 802-812 [PMID: 23430039 DOI: 10.3748/wjg.v19.i6.802]
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/802.htm
Number Citing Articles
1
Yuriko Adkins, Dawn M. Fedor, Bruce E. Mackey, Jian Wu, Darshan S. Kelley. Dietary docosahexaenoic acid reverses nonalcoholic steatohepatitis and fibrosis caused by conjugated linoleic acid supplementation in mice. Journal of Functional Foods 2016; 20: 443 doi: 10.1016/j.jff.2015.11.028
2
Elena Omelchenko, Dov Gavish, Marina Shargorodsky. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. Journal of the American Society of Hypertension 2014; 8(6): 376 doi: 10.1016/j.jash.2014.03.002
3
Asieh Mansour, Soudabe Motamed, Azita Hekmatdoost, Sara Karimi, Mohammad Reza Mohajeri-Tehrani, Mohammad Abdollahi, Reihane Jelodar, Sayed Mahmoud Sajjadi-Jazi. Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30945-w
4
Manjunath Ramanjaneya, Jayakumar Jerobin, Ilham Bettahi, Kodappully Sivaraman Siveen, Abdul-Badi Abou-Samra. Emerging roles of C1Q tumor necrosis factor-related proteins in metabolic diseases. Translational Medicine Communications 2021; 6(1) doi: 10.1186/s41231-021-00083-4
5
Hong Wang, Sara Kuusela, Rita Rinnankoski-Tuikka, Vincent Dumont, Rim Bouslama, Usama Abo Ramadan, Jo Waaler, Anni-Maija Linden, Nai-Wen Chi, Stefan Krauss, Eija Pirinen, Sanna Lehtonen. Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice. International Journal of Obesity 2020; 44(8): 1691 doi: 10.1038/s41366-020-0573-z
6
Andrew Ndakotsu, Govinathan Vivekanandan. The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022;  doi: 10.7759/cureus.25380
7
Misaq Heydari, María Eugenia Cornide-Petronio, Mónica B. Jiménez-Castro, Carmen Peralta. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?. International Journal of Molecular Sciences 2020; 21(15): 5242 doi: 10.3390/ijms21155242
8
Daniel Fernández-Bergés, Luciano Consuegra-Sánchez, Judith Peñafiel, Antonio Cabrera de León, Joan Vila, Francisco Javier Félix-Redondo, Antonio Segura-Fragoso, José Lapetra, María Jesús Guembe, Tomás Vega, Montse Fitó, Roberto Elosua, Oscar Díaz, Jaume Marrugat. Metabolic and Inflammatory Profiles of Biomarkers in Obesity, Metabolic Syndrome, and Diabetes in a Mediterranean Population. DARIOS Inflammatory Study. Revista Española de Cardiología (English Edition) 2014; 67(8): 624 doi: 10.1016/j.rec.2013.10.019
9
Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein & Cell 2018; 9(2): 164 doi: 10.1007/s13238-017-0436-0
10
David Ipsen, Pernille Tveden-Nyborg, Jens Lykkesfeldt. Does Vitamin C Deficiency Promote Fatty Liver Disease Development?. Nutrients 2014; 6(12): 5473 doi: 10.3390/nu6125473
11
Giovanni Tarantino, Vincenzo Citro. Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?. International Journal of Molecular Sciences 2024; 25(4): 1993 doi: 10.3390/ijms25041993
12
M. Georgoulis, M. D. Kontogianni, A. Margariti, D. Tiniakos, E. Fragopoulou, R. Zafiropoulou, G. Papatheodoridis. Associations between dietary intake and the presence of the metabolic syndrome in patients with non‐alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics 2015; 28(4): 409 doi: 10.1111/jhn.12323
13
Maria B. Badia-Tahull, Elisabet Leiva-Badosa, Ramon Jodar-Masanes, Josep Maria Ramon-Torrell, Josep Llop-Talaveron. The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patients. Nutrition Journal 2015; 14(1) doi: 10.1186/s12937-015-0048-6
14
Chang‐Hoon Lee, Seung Ho Choi, Goh Eun Chung, Boram Park, Min‐Sun Kwak. Nonalcoholic fatty liver disease is associated with decreased lung function. Liver International 2018; 38(11): 2091 doi: 10.1111/liv.13860
15
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4): 687 doi: 10.3390/livers3040045
16
Yik Lung Chan, Sonia Saad, David Simar, Brian Oliver, Kristine McGrath, David van Reyk, Paul P Bertrand, Cathy Gorrie, Carol Pollock, Hui Chen. Short term exendin‐4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams. International Journal of Developmental Neuroscience 2015; 46(1): 67 doi: 10.1016/j.ijdevneu.2015.05.009
17
Syed Afroz Keramat, Khorshed Alam, Rabeya Basri, Farzana Siddika, Zubayer Hassan Siddiqui, Joshua Okyere, Abdul-Aziz Seidu, Bright Opoku Ahinkorah. Sleep duration, sleep quality and the risk of being obese: Evidence from the Australian panel survey. Sleep Medicine 2023; 109: 56 doi: 10.1016/j.sleep.2023.06.012
18
Priya Handa, Bryan D. Maliken, James E. Nelson, Vicki Morgan-Stevenson, Donald J. Messner, Barjinderjit K. Dhillon, Heather M. Klintworth, Mary Beauchamp, Matthew M. Yeh, Clinton T. Elfers, Christian L. Roth, Kris V. Kowdley. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Hepatology 2014; 60(1): 133 doi: 10.1002/hep.26946
19
Teresa Vanessa Fiorentino, Maria Adelaide Marini, Elena Succurro, Francesco Andreozzi, Angela Sciacqua, Marta Letizia Hribal, Francesco Perticone, Giorgio Sesti. Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. Diabetes Research and Clinical Practice 2017; 134: 53 doi: 10.1016/j.diabres.2017.09.017
20
Kaviyarasi Renu, Sruthy K.B., Sujitha Parthiban, Sugunapriyadharshini S., Alex George, Tirupathi Pichiah P.B., Shubhankar Suman, Abilash V.G., Sankarganesh Arunachalam. Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance. European Journal of Pharmacology 2019; 843: 162 doi: 10.1016/j.ejphar.2018.11.018
21
Samaneh Hosseinabadi, Maryam Rafraf, Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Shohreh Vojouhi. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Complementary Therapies in Medicine 2020; 49: 102290 doi: 10.1016/j.ctim.2019.102290
22
Jeshwanth Jangam, A Padma Vijayasree, M Venkateswarlu, J Helena Rajkumari. PREVALENCE OF ELEVATED AST, ALT, ALP IN TYPE 2 DIABETES MELLITUS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2023; : 39 doi: 10.36106/ijsr/7001394
23
Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics 2020; 10(8): 579 doi: 10.3390/diagnostics10080579
24
Maria José Rodríguez, Francisca Herrera, Wendy Donoso, Iván Castillo, Roxana Orrego, Daniel R. González, Jessica Zúñiga-Hernández. Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation. International Journal of Molecular Sciences 2020; 21(22): 8827 doi: 10.3390/ijms21228827
25
Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Huan Nie, Maoxing Pan, Runsen Chen, Jiqian Xie, Qinhe Yang, Yupei Zhang. Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/9701285
26
Jieling Xiao, Lincoln Kai En Lim, Cheng Han Ng, Darren Jun Hao Tan, Wen Hui Lim, Cyrus S. H. Ho, Eunice Xiang Xuan Tan, Arun J. Sanyal, Mark D. Muthiah. Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.691696
27
Letícia BALTIERI, Elinton Adami CHAIM, Felipe David Mendonça CHAIM, Murillo Pimentel UTRINI, Martinho Antonio GESTIC, Everton CAZZO. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. Arquivos de Gastroenterologia 2018; 55(3): 247 doi: 10.1590/s0004-2803.201800000-62
28
Carmine Finelli. Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease. Gastrointestinal Disorders 2023; 5(2): 243 doi: 10.3390/gidisord5020020
29
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
30
Peter R. van Dijk, Amaal Eman Abdulle, Marian L.C. Bulthuis, Frank G. Perton, Margery A. Connelly, Harry van Goor, Robin P.F. Dullaart. The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL. Journal of Clinical Medicine 2019; 9(1): 49 doi: 10.3390/jcm9010049
31
Wen Ji Chen, Bing Cai, Hui Ting Chen, Chuang Yu Cao, Yan Lei Du, Yu Yuan Li, Yu Qiang Nie, Yong Jian Zhou. Retracted: The role of ADIPOQ methylation in curcumin‐administrated experimental nonalcoholic fatty liver disease. Journal of Digestive Diseases 2016; 17(12): 829 doi: 10.1111/1751-2980.12431
32
Jayagopalan Veena, Anjaneyulu Muragundla, Srinivas Sidgiddi, Swaminathan Subramaniam. Non-alcoholic fatty liver disease: need for a balanced nutritional source. British Journal of Nutrition 2014; 112(11): 1858 doi: 10.1017/S0007114514002591
33
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
34
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D. Byrne, Giovanni Targher. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nature Reviews Endocrinology 2022; 18(10): 638 doi: 10.1038/s41574-022-00711-5
35
Lili Chen, Xiaolong Zhao, Guangjun Liang, Jiuru Sun, Zhifeng Lin, Renming Hu, Peili Chen, Zhaoyun Zhang, Linuo Zhou, Yiming Li. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis. Nutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0208-0
36
Jia Liu, Guang Wang, Yumei Jia, Yuan Xu. GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease. Diabetes/Metabolism Research and Reviews 2015; 31(4): 329 doi: 10.1002/dmrr.2580
37
Tania Gamberi, Francesca Magherini, Alessandra Modesti, Tania Fiaschi. Adiponectin Signaling Pathways in Liver Diseases. Biomedicines 2018; 6(2): 52 doi: 10.3390/biomedicines6020052
38
Maria Eliza de Castro Moreira, Fernanda de Oliveira Araújo, Andressa Rodrigues de Sousa, Renata Celi Lopes Toledo, Laércio dos Anjos Benjamin, Marcia Paranho Veloso, Kassius de Souza Reis, Marcelo Henrique dos Santos, Hercia Stampini Duarte Martino. Bacupari peel extracts (Garcinia brasiliensis) reduces the biometry, lipogenesis and hepatic steatosis in obese rats. Food Research International 2018; 114: 169 doi: 10.1016/j.foodres.2018.08.004
39
Na-young Yoo, Sookyoung Jeon, Yerim Nam, Youn-Jin Park, Sae Bom Won, Young Hye Kwon. Dietary Supplementation of Genistein Alleviates Liver Inflammation and Fibrosis Mediated by a Methionine-Choline-Deficient Diet in db/db Mice. Journal of Agricultural and Food Chemistry 2015; 63(17): 4305 doi: 10.1021/acs.jafc.5b00398
40
Hoi Kin Wong, Kwok Leung Ong, Raymond Y. H. Leung, Tommy T. Cheung, Aimin Xu, Tai Hing Lam, Karen S. L. Lam, Bernard M. Y. Cheung, Sompop Bencharit. Plasma Level of Adrenomedullin Is Influenced by a Single Nucleotide Polymorphism in the Adiponectin Gene. PLoS ONE 2013; 8(8): e70335 doi: 10.1371/journal.pone.0070335
41
Man Kong, Chaoqun Liu, Yanfang Guo, Qing Gao, Chunrong Zhong, Xuezhen Zhou, Renjuan Chen, Guoping Xiong, Xuefeng Yang, Liping Hao, Nianhong Yang. Higher level of GGT during mid‐pregnancy is associated with increased risk of gestational diabetes mellitus. Clinical Endocrinology 2018; 88(5): 700 doi: 10.1111/cen.13558
42
Reyhane Ebrahimi, Mehrnoosh Shanaki, Samaneh Mohassel Azadi, Alireza Bahiraee, Amir Reza Radmard, Hossein Poustchi, Solaleh Emamgholipour. Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?. Archives of Physiology and Biochemistry 2022; 128(1): 24 doi: 10.1080/13813455.2019.1661496
43
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
44
Deborah Crombez, Sébastien Delcambre, Denis Nonclercq, Luce Vander Elst, Sophie Laurent, Miriam Cnop, Robert N. Muller, Carmen Burtea. Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models. Journal of Drug Targeting 2020; 28(7-8): 831 doi: 10.1080/1061186X.2019.1710840
45
Bhavimani Guru, Akhilesh K. Tamrakar, S.N. Manjula, B.R. Prashantha Kumar. Novel dual PPARα/γ agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects. European Journal of Pharmacology 2022; 935: 175322 doi: 10.1016/j.ejphar.2022.175322
46
Sho Tanaka, Midori Fujishiro, Kentaro Watanabe, Kazuhiro Imatake, Yasuyuki Suzuki, Masanori Abe, Hisamitsu Ishihara, Shigemasa Tani. Effect of Adult Weight Gain on Non-Alcoholic Fatty Liver Disease and Its Association with Anthropometric Parameters in the Lean Japanese Population. Diagnostics 2020; 10(11): 863 doi: 10.3390/diagnostics10110863
47
Xiaoli Pan, Pei Wang, Jinzhuo Luo, Zhijun Wang, Yuhu Song, Jin Ye, Xiaohua Hou. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients. Endocrine 2015; 48(3): 834 doi: 10.1007/s12020-014-0384-x
48
Nesrin İnceören, Feryal Akay, Cemal Nas, Engin Deveci, Göksel Kızıl, Murat Kızıl. Antiglycative Effect of Combination of Extracts of Capsicum annuum (chilli) and Pyridoxamine Against Glycation in Streptozotocin-induced Experimental Diabetes in Rats. Revista Brasileira de Farmacognosia 2023; 33(4): 831 doi: 10.1007/s43450-023-00414-6
49
Giovanni Tarantino, Vincenzo Citro. What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02031-1
50
Bipradas Roy, Suresh Selvaraj Palaniyandi. Tissue-specific role and associated downstream signaling pathways of adiponectin. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00587-4
51
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hiroko Iijima. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. International Journal of Molecular Sciences 2021; 22(4): 1917 doi: 10.3390/ijms22041917
52
Eun‐Jeong Joo, Yoosoo Chang, Joon‐Sup Yeom, Seungho Ryu. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. Hepatology 2017; 65(3): 828 doi: 10.1002/hep.28917
53
Shuang Zhao, Shuman Zhang, Weiwei Zhang, Yi Gao, Chengbo Rong, Hexiang Wang, Yu Liu, Jack Ho Wong, Tzibun Ng. First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49925-0
54
İsmail Mücahit Alptekin, Funda Pınar Çakıroğlu, Saba Kiremitci, Tuba Reçber, Emirhan Nemutlu. Inulin may prevent steatosis by suppressing cannabinoid receptor-1 and patatin-like phospholipase-3 expression in liver. Nutrition 2022; : 111742 doi: 10.1016/j.nut.2022.111742
55
Nadia Panera, Claudia Della Corte, Annalisa Crudele, Laura Stronati, Valerio Nobili, Anna Alisi. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines. Expert Review of Gastroenterology & Hepatology 2016; 10(3): 393 doi: 10.1586/17474124.2016.1110485
56
Esteban Jorge-Galarza, Aida Medina-Urrutia, Rosalinda Posadas-Sánchez, Carlos Posadas-Romero, Guillermo Cardoso-Saldaña, Gilberto Vargas-Alarcón, Nacú Caracas-Portilla, Carmen González-Salazar, Margarita Torres-Tamayo, Juan Gabriel Juárez-Rojas. Adipose tissue dysfunction increases fatty liver association with pre diabetes and newly diagnosed type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 2016; 8(1) doi: 10.1186/s13098-016-0189-6
57
Daniel Fernández-Bergés, Luciano Consuegra-Sánchez, Judith Peñafiel, Antonio Cabrera de León, Joan Vila, Francisco Javier Félix-Redondo, Antonio Segura-Fragoso, José Lapetra, María Jesús Guembe, Tomás Vega, Montse Fitó, Roberto Elosua, Oscar Díaz, Jaume Marrugat. Perfil metabólico-inflamatorio en la transición obesidad, síndrome metabólico y diabetes mellitus en población mediterránea. Estudio DARIOS Inflamatorio. Revista Española de Cardiología 2014; 67(8): 624 doi: 10.1016/j.recesp.2013.10.021
58
Shu-chao Pang, Shuo Wang, Mei-ling Chen, Jun-ping Zhang, Yuan-yuan Wang, Hui-yun Jia, Li-yuan Bi, Hui Wang. BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE-/- Mice. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/8986038
59
Hye-Ran Ahn, Min-Ho Shin, Hae-Sung Nam, Kyeong-Soo Park, Young-Hoon Lee, Seul-Ki Jeong, Jin-Su Choi, Sun-Seog Kweon. The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetology & Metabolic Syndrome 2014; 6(1) doi: 10.1186/1758-5996-6-14
60
Dulshan Jayasekera, Phillipp Hartmann. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World Journal of Hepatology 2023; 15(5): 609-640 doi: 10.4254/wjh.v15.i5.609
61
Emma Börgeson, Andrew M.F. Johnson, Yun Sok Lee, Andreas Till, Gulam Hussain Syed, Syed Tasadaque Ali-Shah, Patrick J. Guiry, Jesmond Dalli, Romain A. Colas, Charles N. Serhan, Kumar Sharma, Catherine Godson. Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease. Cell Metabolism 2015; 22(1): 125 doi: 10.1016/j.cmet.2015.05.003
62
Yong Jiang, Tao Han, Zhi‐Guang Zhang, Man Li, Feng‐Xiang Qi, Ying Zhang, Ying‐Lan Ji. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic Diseases and Translational Medicine 2017; 3(3): 165 doi: 10.1016/j.cdtm.2017.06.003
63
Vanda Marques, Marta B. Afonso, Nina Bierig, Filipa Duarte-Ramos, Álvaro Santos-Laso, Raul Jimenez-Agüero, Emma Eizaguirre, Luis Bujanda, Maria J. Pareja, Rita Luís, Adília Costa, Mariana V. Machado, Cristina Alonso, Enara Arretxe, José M. Alustiza, Marcin Krawczyk, Frank Lammert, Dina G. Tiniakos, Bertram Flehmig, Helena Cortez-Pinto, Jesus M. Banales, Rui E. Castro, Andrea Normann, Cecília M. P. Rodrigues. Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.683250
64
Yoon-Young Sung, Dong-Seon Kim, Seung-Hyung Kim, Ho Kyoung Kim. Aqueous and ethanolic extracts of welsh onion, Allium fistulosum, attenuate high-fat diet-induced obesity. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2152-6
65
Xinqian Gu, Xiao Luo, Yanxin Wang, Zhangya He, Xiaomin Li, Kunjin Wu, Yifan Zhang, Yafeng Yang, Jing Ji, Xiaoqin Luo. Ascorbic acid attenuates cell stress by activating the�fibroblast growth factor 21/fibroblast growth factor receptor�2/adiponectin pathway in HepG2 cells. Molecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10457
66
Qingzhi Huang, Hana Yu, Xin Zhong, Ying Tian, Zhenhua Cui, Zhenyu Quan. Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study. Journal of Human Hypertension 2022; 37(4): 313 doi: 10.1038/s41371-022-00686-w
67
Guy Bower, Tania Toma, Leanne Harling, Long R Jiao, Evangelos Efthimiou, Ara Darzi, Thanos Athanasiou, Hutan Ashrafian. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. Obesity Surgery 2015; 25(12): 2280 doi: 10.1007/s11695-015-1691-x
68
Cheng Han Ng, Margaret LP Teng, Nicholas WS Chew, Kai En Chan, Jie Ning Yong, Jingxuan Quek, Darren Jun Hao Tan, Wen Hui Lim, Gabriel Sheng Jie Lee, Jessica Wong, Apichat Kaewdech, Daniel Q Huang, Jiongwei Wang, Mark Y Chan, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun Sanyal, Mark Muthiah. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals. Expert Review of Gastroenterology & Hepatology 2022; 16(9): 895 doi: 10.1080/17474124.2022.2119128
69
Cheng Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Lay Hoon Goh, Kamala Devi, Nicholas WS Chew, Lung-Yi Loey Mak, Nobuharu Tamaki, Daniel Q. Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Rohit Loomba, Arun Sanyal, Mark Muthiah. Living in the Nonalcoholic Fatty Liver Disease (NAFLD) Silent Epidemic. A Systematic Review of Patients’ Perspective. SSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4059221
70
Xiao Yuan, Tomohiko Nakao, Hina Satone, Kazuyuki Ohara, Yuri Kominami, Miho Ito, Teruki Aizawa, Tomoya Ueno, Hideki Ushio. The Effects of Brown Algae-Derived Monosaccharide L-Fucose on Lipid Metabolism in C57BL/6J Obese Mice. Nutrients 2020; 12(12): 3798 doi: 10.3390/nu12123798
71
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
72
Xiaowei Sun, Rennan Feng, Yanchuan Li, Song Lin, Wei Zhang, Ying Li, Changhao Sun, Songtao Li. Histidine supplementation alleviates inflammation in the adipose tissue of high-fat diet-induced obese rats via the NF-κB- and PPARγ-involved pathways. British Journal of Nutrition 2014; 112(4): 477 doi: 10.1017/S0007114514001056
73
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
74
Soheila Jangjo-Borazjani, Maryam Dastgheib, Efat Kiyamarsi, Roghayeh Jamshidi, Saleh Rahmati-Ahmadabad, Masoumeh Helalizadeh, Roya Iraji, Stephen M Cornish, Shiva Mohammadi-Darestani, Zohreh Khojasteh, Mohammad Ali Azarbayjani. Effects of resistance training and nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production. Archives of Physiology and Biochemistry 2023; 129(4): 913 doi: 10.1080/13813455.2021.1886117
75
Yuanli Wang, Rulong Chen, Jingyi Li, Guodong Zeng, Juntao Yuan, Jingran Su, Chunyan Wu, Zhongbing Lu, Fang Zhang, Wenjun Ding. Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation. Antioxidants 2022; 11(6): 1093 doi: 10.3390/antiox11061093
76
Ian James Martins. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018;  doi: 10.5772/intechopen.70581
77
Chi-Ming Tai, Ming-Lung Yu, Hung-Pin Tu, Chih-Kun Huang, Jau-Chung Hwang, Wan-Long Chuang. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity. Surgery for Obesity and Related Diseases 2017; 13(4): 686 doi: 10.1016/j.soard.2016.11.028
78
Farouk K. El-Baz, Dalia O. Saleh, Gehad A. Abdel Jaleel, Rehab A. Hussein. Attenuation of Age-Related Hepatic Steatosis by Dunaliella salina Microalgae in Senescence Rats through the Regulation of Redox Status, Inflammatory Indices, and Apoptotic Biomarkers. Advances in Pharmacological and Pharmaceutical Sciences 2020; 2020: 1 doi: 10.1155/2020/3797218
79
Sarah WERNLY, Bernhard WERNLY, Georg SEMMLER, Andreas VÖLKERER, Richard REZAR, Lorenz SEMMLER, Felix STICKEL, Elmar AIGNER, David NIEDERSEER, Christian DATZ. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort. Minerva Medica 2023; 113(6) doi: 10.23736/S0026-4806.22.07928-9
80
E. Passos, C.D. Pereira, I.O. Gonçalves, S. Rocha-Rodrigues, N. Silva, J.T. Guimarães, D. Neves, A. Ascensão, J. Magalhães, M.J. Martins. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sciences 2015; 123: 51 doi: 10.1016/j.lfs.2014.12.013
81
Dana El Masri, Leila Itani, Dima Kreidieh, Hana Tannir, Marwan El Ghoch. Predictive Equations Based on Body Composition for Resting Energy Expenditure Estimation in Adults with Obesity. Current Diabetes Reviews 2020; 16(4): 381 doi: 10.2174/1573399815666191030085915
82
Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(19): 3407-3417 doi: 10.3748/wjg.v23.i19.3407
83
Tomislav Kizivat, Ivana Maric, Dunja Mudri, Ines Bilic Curcic, Dragan Primorac, Martina Smolic. Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00027
84
Cheng Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Clarissa Elysia Fu, Ansel Shao Pin Tang, Lay Hoon Goh, Kamala Devi, Nicholas W. S. Chew, Lung‐Yi Loey Mak, Nobuharu Tamaki, Daniel Q. Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Rohit Loomba, Arun J. Sanyal, Mark Muthiah. Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives. Alimentary Pharmacology & Therapeutics 2022; 56(4): 570 doi: 10.1111/apt.17121
85
Vali Musazadeh, Parvin Dehghan, Manouchehr Khoshbaten. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial. European Journal of Gastroenterology & Hepatology 2022; 34(5): 537 doi: 10.1097/MEG.0000000000002297
86
Raika Jamali, Mohsen Razavizade, Abbas Arj, Mohammad Hossein Aarabi. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(21): 5096-5103 doi: 10.3748/wjg.v22.i21.5096
87
I-Pin Chou, Yao-Pang Chiu, Shih-Torng Ding, Bing-Hsien Liu, Yuan Yu Lin, Ching-Yi Chen. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice – possible involvement of oxidative stress and autophagy. Endocrine Research 2014; 39(4): 173 doi: 10.3109/07435800.2013.879165
88
Xiaobin Zheng, Fen Xu, Hua Liang, Huanyi Cao, Mengyin Cai, Wen Xu, Jianping Weng. SIRT1/HSF1/HSP pathway is essential for exenatide‐alleviated, lipid‐induced hepatic endoplasmic reticulum stress. Hepatology 2017; 66(3): 809 doi: 10.1002/hep.29238
89
Andrea Bell, Soheila Korourian, Huawei Zeng, Joshua Phelps, Reza Hakkak. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model. Food & Function 2017; 8(3): 1293 doi: 10.1039/C6FO01772J
90
Marie Boyle, Steven Masson, Quentin M. Anstee. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology 2018; 68(2): 251 doi: 10.1016/j.jhep.2017.11.006
91
Stephen Malnick, Yaakov Maor. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. Visceral Medicine 2020; 36(3): 198 doi: 10.1159/000507233
92
佳佳 魏. Recent Advances in Visceral Obesity and Related Diseases. Advances in Clinical Medicine 2022; 12(12): 11686 doi: 10.12677/ACM.2022.12121684
93
Mi Kyung Shin, Soo-Man Yang, In-Seob Han. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Animal Cells and Systems 2020; 24(4): 214 doi: 10.1080/19768354.2020.1810771
94
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Nicht‐alkoholische Fettlebererkrankung und Psoriasis – besteht ein gemeinsames proinflammatorisches Netzwerk?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425_g
95
Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Molecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
96
Matteo Tardelli, Veronica Moreno‐Viedma, Maximilian Zeyda, Bianca K Itariu, Felix B Langer, Gerhard Prager, Thomas M Stulnig. Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. Journal of Gastroenterology and Hepatology 2017; 32(1): 253 doi: 10.1111/jgh.13415
97
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
98
Cuong D Tran, Desma M Grice, Ben Wade, Caroline A Kerr, Denis C Bauer, Dongmei Li, Garry N Hannan. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiology 2015; 10(8): 1339 doi: 10.2217/FMB.15.54
99
Shuo-Yan Gau, Kuang-Hua Huang, Chiu Hsiang Lee, Yu-Hsiang Kuan, Tung-Han Tsai, Chien-Ying Lee. Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.840106
100
Safoora Nabavi, Maryam Rafraf, Mohammad-hossein Somi, Aziz Homayouni-Rad, Mohammad Asghari-Jafarabadi. Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD). Journal of Functional Foods 2015; 18: 684 doi: 10.1016/j.jff.2015.08.031
101
Piriyah Sinclair, Neil Docherty, Carel W le Roux. Metabolic Effects of Bariatric Surgery. Clinical Chemistry 2018; 64(1): 72 doi: 10.1373/clinchem.2017.272336
102
Geng‐Ruei Chang, Po‐Hsun Hou, Chao‐Min Wang, Ching‐Feng Wu, Huang‐Kai Su, Huei‐Jyuan Liao, To‐Pang Chen. Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance. Pharmacology Research & Perspectives 2021; 9(2) doi: 10.1002/prp2.732
103
Ji Woo Baek, Sun Ha Jee. Incidence of diabetes mellitus according to body mass index and gamma-glutamyltransferase level in Korea. Journal of Global Health Science 2022; 4(2) doi: 10.35500/jghs.2022.4.e18
104
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017; 72: 94 doi: 10.1016/j.metabol.2017.04.011
105
Ker Ming Seaw, Christiani Jeyakumar Henry, Xinyan Bi. Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic Review. Livers 2023; 3(3): 463 doi: 10.3390/livers3030033
106
Sechang Oh, Takashi Shida, Kazumasa Yamagishi, Kiyoji Tanaka, Rina So, Takehiko Tsujimoto, Junichi Shoda. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study. Hepatology 2015; 61(4): 1205 doi: 10.1002/hep.27544
107
Anushree Nagaraj, Sarah Andrea Wilson, Lalitha Vaidyanathan. Anti-Obesity Properties of Calocybe Indica in Zebra fishes with Short-Term High-Fat Diet Induction. Biomedical and Pharmacology Journal 2021; 14(1): 411 doi: 10.13005/bpj/2141
108
Elham Karimi-Sales, Gisou Mohaddes, Mohammad Reza Alipour. Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases. Archives of Physiology and Biochemistry 2024; 130(1): 38 doi: 10.1080/13813455.2021.1962913
109
Griselda M. Rabadán-Chávez, Angel Miliar Garcia, Norma Paniagua Castro, Gerardo Escalona Cardoso, Lucia Quevedo-Corona, Elba Reyes-Maldonado, María Eugenia Jaramillo-Flores. Modulating the expression of genes associated with hepatic lipid metabolism, lipoperoxidation and inflammation by cocoa, cocoa extract and cocoa flavanols related to hepatic steatosis induced by a hypercaloric diet. Food Research International 2016; 89: 937 doi: 10.1016/j.foodres.2016.03.019
110
Rashid Ali Khan, Uma Bhandari, Prem Kapur, Abhinav Jain, Farrukh Farah. Effects of rosuvastatin (added to hypocaloric diet) on serum periostin, adiponectin, proinflammtory cytokines levels and hepatic steatosis in non-alcoholic fatty liver disease patients with dyslipidemia. Clinical Epidemiology and Global Health 2019; 7(1): 53 doi: 10.1016/j.cegh.2017.12.010
111
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
112
Enrique Linden-Torres, Graciela Zambrano-Galván, Amirhossein Sahebkar, Mayela Ríos-Mier, Luis E. Simental-Mendía. Coffee consumption has no effect on circulating markers of liver function but increases adiponectin concentrations: A systematic review and meta-analysis of randomized controlled trials. Nutrition Research 2022; 106: 24 doi: 10.1016/j.nutres.2022.07.010
113
German Santamaria Rodriguez, Alvaro Morales Prado. Ulcerative colitis and lymphoproliferative. Gastroenterology & Hepatology: Open Access 2019; 10(3): 132 doi: 10.15406/ghoa.2019.10.00371
114
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics 2021; 11(1): 98 doi: 10.3390/diagnostics11010098
115
Young Jang, Zhiqiang Wang, Jeong-Min Lee, Jae-Young Lee, Soon Lim. Screening of Korean Natural Products for Anti-Adipogenesis Properties and Isolation of Kaempferol-3-O-rutinoside as a Potent Anti-Adipogenetic Compound from Solidago virgaurea. Molecules 2016; 21(2): 226 doi: 10.3390/molecules21020226
116
Zhangya He, Xiaomin Li, Hexiang Yang, Pei Wu, Shanshan Wang, Dan Cao, Xiaoxiao Guo, Zhangrui Xu, Jiayi Gao, Wanyu Zhang, Xiaoqin Luo. Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.745609
117
Lijun Zhu, Zhengmei Fang, Yuelong Jin, Weiwei Chang, Mengyun Huang, Lianping He, Yan Chen, Yingshui Yao. Association between serum alanine and aspartate aminotransferase and blood pressure: a cross-sectional study of Chinese freshmen. BMC Cardiovascular Disorders 2021; 21(1) doi: 10.1186/s12872-021-02282-1
118
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Basic Protocols in Foods and Nutrition. Methods and Protocols in Food Science 2022; : 53 doi: 10.1007/978-1-0716-2345-9_4
119
Vishal Sarsani, Sarah M. Brotman, Yin Xianyong, Lillian Fernandes Silva, Markku Laakso, Cassandra N. Spracklen. A cross-ancestry genome-wide meta-analysis, fine-mapping, and gene prioritization approach to characterize the genetic architecture of adiponectin. Human Genetics and Genomics Advances 2024; 5(1): 100252 doi: 10.1016/j.xhgg.2023.100252
120
Daniele de Souza Marinho do Nascimento, Ruth Oliveira, Rafael Camara, Dayanne Gomes, Jessika Monte, Mariana Costa, Júlia Fernandes, Silvana Langassner, Hugo Rocha. Baccharis trimera (Less.) DC Exhibits an Anti-Adipogenic Effect by Inhibiting the Expression of Proteins Involved in Adipocyte Differentiation. Molecules 2017; 22(6): 972 doi: 10.3390/molecules22060972
121
Yamuna Sucedaram, Edward James Johns, Ruby Husain, Munavvar Abdul Sattar, Mohammed H Abdulla, Giribabu Nelli, Nur Syahrina Rahim, Manizheh Khalilpourfarshbafi, Nor Azizan Abdullah. Exposure to High-Fat Style Diet Induced Renal and Liver Structural Changes, Lipid Accumulation and Inflammation in Intact and Ovariectomized Female Rats. Journal of Inflammation Research 2021; : 689 doi: 10.2147/JIR.S299083
122
艳江 鲍. Investigation and Analysis on Civil Servants’ Cardiovascular Risk Factors of a Town in Beijing Daxing District. Asian Case Reports in Vascular Medicine 2018; 6(01): 1 doi: 10.12677/ACRVM.2018.61001
123
Shiful Islam, Sadaqur Rahman, Tangigul Haque, Abu Hasan Sumon, AZ Mahbub Ahmed, Nurshad Ali. Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross‐sectional study in Bangladeshi adults. Endocrinology, Diabetes & Metabolism 2020; 3(2) doi: 10.1002/edm2.116
124
Jun Wang, Xu‐Feng Guo, Shi‐Jie Yu, Jia Song, Ji‐Xiang Zhang, Zhuo Cao, Jing Wang, Meng‐Yao Ji, Wei‐Guo Dong. Adiponectin polymorphisms and non‐alcoholic fatty liver disease risk: A meta‐analysis. Journal of Gastroenterology and Hepatology 2014; 29(7): 1396 doi: 10.1111/jgh.12562
125
Eline H. van den Berg, Eke G. Gruppen, Hans Blokzijl, Stephan J.L. Bakker, Robin P.F. Dullaart. Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study. Journal of Clinical Medicine 2019; 8(12): 2157 doi: 10.3390/jcm8122157
126
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
127
E. Sabath, A. Báez‐Ruiz, R. M. Buijs. Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization. Obesity Reviews 2015; 16(10): 871 doi: 10.1111/obr.12308
128
Carmine Finelli, Luigi Sommella, Saverio Gioia, Nicolina La Sala, Giovanni Tarantino. Should visceral fat be reduced to increase longevity?. Ageing Research Reviews 2013; 12(4): 996 doi: 10.1016/j.arr.2013.05.007
129
Jin Chen, Bingtian Liang, Dongxue Bian, Yan Luo, Jing Yang, Zhihui Li, Zhengjie Zhuang, Shufei Zang, Junping Shi. Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism. Biochemical and Biophysical Research Communications 2019; 518(4): 691 doi: 10.1016/j.bbrc.2019.08.111
130
Jin-Hyun Yu, Jin-Seok Kim, Mee-Ra Lee, Seong-Yong Yoon, Seong-Yong Cho, Seung-Hyun Yoo, Boo-Il Kim. Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers. Annals of Occupational and Environmental Medicine 2016; 28(1) doi: 10.1186/s40557-016-0105-4
131
Andrea Morán-Costoya, Ana M. Proenza, Magdalena Gianotti, Isabel Lladó, Adamo Valle. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver–Adipose Tissue Crosstalk. Antioxidants & Redox Signaling 2021; 35(9): 753 doi: 10.1089/ars.2021.0044
132
Anna-Sophia Leven, Robert K. Gieseler, Martin Schlattjan, Thomas Schreiter, Marco Niedergethmann, Theodor Baars, Hideo A. Baba, Mustafa K. Özçürümez, Jan-Peter Sowa, Ali Canbay. Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD. Adipocyte 2021; 10(1): 558 doi: 10.1080/21623945.2021.1982164
133
Mahdieh Abbasalizad Farhangi, Parvin Dehghan, Vali Musazadeh, Maryam Kavyani, Parham Maleki. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Journal of Functional Foods 2022; 92: 105074 doi: 10.1016/j.jff.2022.105074
134
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
135
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425
136
Carmine Finelli. Gut Microbiota, NAFLD and COVID-19: A Possible Interaction. Obesities 2022; 2(2): 215 doi: 10.3390/obesities2020017
137
Valerio Caputo, Giovanni Tarantino, Silvano Junior Santini, Giovanna Fracassi, Clara Balsano. The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression. Nutrients 2023; 15(22): 4757 doi: 10.3390/nu15224757
138
Robin P.F. Dullaart, Eline H. van den Berg, Melanie M. van der Klauw, Hans Blokzijl. Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people. Clinical Biochemistry 2014; 47(12): 1028 doi: 10.1016/j.clinbiochem.2014.04.016
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345